title: [Irinotecan chemotherapy for patients with advanced or relapsed pancreatic neoplasm].
authors.affiliation: Department of Gastroenterology, Showa University, Toyosu Hospital.
authors.forename: Takashi
authors.initials: T
authors.lastname: Sekikawa
authors.forename: Akiko
authors.initials: A
authors.lastname: Akaike
authors.forename: Jun
authors.initials: J
authors.lastname: Ushio
authors.forename: Atsushi
authors.initials: A
authors.lastname: Sato
authors.forename: Masaaki
authors.initials: M
authors.lastname: Matsukawa
mesh_terms: D000972:Antineoplastic Agents, Phytogenic / Q000493:pharmacokinetics / Q000627:therapeutic use*; D002166:Camptothecin / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D006801:Humans; D000077146:Irinotecan; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy; D010190:Pancreatic Neoplasms / Q000188:drug therapy*
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D000077146:Irinotecan; D002166:Camptothecin